logo

For the Inventor, By the Inventor

Göttingen, Germany

Reimar Schlingensiepen

This inventor holds 8 USPTO granted patents. Top assignees: Biognostik Gesellschaft Fur Biomolekulare Diagnostik Mbh, Antisense Pharma Gmbh, Other. Active years: 2002-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Reimar Schlingensiepen. Retrieved from https://idiyas.com/inventor/reimar-schlingensiepen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 50.0

Average Co-Inventor Count = 2.9

ph-index = 3

Forward Citations = 63(Granted Patents)


Location History:

  • Gottingen, DE (2002 - 2010)
  • Göttingen, DE (2002 - 2014)
  • Regensburg, DE (2011 - 2014)

Company Filing History:

goldMedal4 out of 4 
 
Biognostik Gesellschaft Fur Biomolekulare Diagnostik Mbh
 patents
silverMedal2 out of 10 
 
Antisense Pharma Gmbh
 patents
bronzeMedal2 out of 834,570 
Other
 patents

Years Active: 2002-2014

Loading Chart...
8 patents (USPTO):Explore Patents
1. 8703729 - Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene (2014-04-22),
2. 8629117 - Method for stimulating the immune system (2014-01-14),
3. 8097597 - Use of low doses of oligonucleotides antisense to TGF-β genes in the treatment of brain tumors (2012-01-17),
4. 7910563 - Antisense oligonucleotide to inhibit melanoma inhibitory activity, MIA (2011-03-22),
5. 7667027 - Antisense-oligonucleotides for the treatment of immuno-suppressive effects of transforming growth factor-β (TGF-β) (2010-02-23),
6. 7326783 - Pharmaceutical composition comprising antisense-nucleic acid for prevention and/or treatment of neuronal injury, degeneration and cell death and for the treatment of neoplasms (2008-02-05),
7. 6455689 - Antisense-oligonucleotides for transforming growth factor-&bgr; (TGF-&bgr;) (2002-09-24),
8. 6365345 - Antisense nucleic acids for the prevention and treatment of disorders in which expression of c-erbB plays a role (2002-04-02),

Title: The Innovations of Reimar Schlingensiepen

Introduction

Reimar Schlingensiepen is a notable inventor based in Göttingen, Germany. He has made significant contributions to the field of biomolecular diagnostics and immunology. With a total of eight patents to his name, Schlingensiepen's work has had a profound impact on medical science.

Latest Patents

Among his latest patents is a mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene. This innovative mixture includes at least one inhibitor or suppressor of the expression of a gene and at least one molecule that binds to the expression product of said gene. Additionally, he has developed a method for stimulating the immune system, which involves a medicament comprising a combination of various components.

Career Highlights

Throughout his career, Schlingensiepen has worked with Biognostik Gesellschaft für Biomolekulare Diagnostik mbH, where he has contributed to advancements in diagnostic technologies. His expertise in biomolecular diagnostics has positioned him as a leader in his field.

Collaborations

Reimar Schlingensiepen has collaborated with notable individuals such as Karl-Hermann Schlingensiepen and Wolfgang Brysch. These collaborations have further enhanced his research and development efforts.

Conclusion

Reimar Schlingensiepen's innovative work and numerous patents reflect his dedication to advancing medical science. His contributions continue to influence the fields of biomolecular diagnostics and immunology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…